A few days after a disappointing clinical trial readout for Syndax Pharma's Revuforj in one form of leukaemia, the company ...

Last night, news broke that President-Elect Donald Trump had nominated Robert F Kennedy Jr (aka RFK Jr) as US Health ...

The Life Sciences Industry Report: Trends & Predictions 2025 is built for those who are serious about growth, innovation, and ...

Summit and Akeso's ivonescimab attracted headlines earlier this year when it was shown to be more effective than anti-PD-1 ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

"Slingshot represents an opportunity to bridge the gap between academic innovation and clinical development of a novel ...

A new report says that London is the top city in Europe for the life sciences industry, and ranks third worldwide after ...

Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) ...

Qu – which, according to Parsa, is the fruit of a collaboration between a global team of experienced AI scientists, ...

From consumer products to clinical trials, anything that is designed without input from its intended recipients will likely feel disconnected from their needs. Conversely, systemically gathering their ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...